dr. petrylak on the results of the ev-103 trial in bladder cancer
Published 4 years ago • 107 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
0:45
prof. siefker-radtke on the ev-103 trial in bladder cancer
-
0:50
dr. petrylak on atezolizumab in bladder cancer
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
1:47
dr. petrylak on sequencing of targeted agents in bladder cancer
-
0:57
dr. petrylak on immunotherapy in bladder cancer
-
1:06
dr. daniel petrylak on early trials for a new urothelial bladder cancer treatment
-
1:02:57
peri-operative therapy in urothelial carcinoma: uromigos live 2024
-
1:08
dr. petrylak on the future immunotherapy in bladder cancer
-
1:29
dr. daniel petrylak on the imvigor study of atezolizumab in advanced bladder cancer
-
1:01
dr. petrylak on novel immunotherapy research in bladder cancer
-
1:05
dr. petrylak on combinations with pembrolizumab in urothelial carcinoma
-
0:57
dr. petrylak on the keynote-045 trial for urothelial carcinoma
-
1:40
dr. petrylak on trial of atezolizumab in urothelial carcinoma
-
0:56
dr. petrylak on ongoing investigations of checkpoint inhibition in bladder cancer
-
0:44
dr. petrylak on the results of the phase ii stride study
-
2:03
dr. petrylak on enfortumab vedotin in locally advanced or metastatic urothelial carcinoma
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
1:41
dr. petrylak on immunotherapy for second-line treatment in bladder cancer